BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6200044)

  • 1. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
    Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
    Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
    Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
    Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
    Kurman RJ; Scardino PT; McIntire KR; Waldmann TA; Javadpour N
    Cancer; 1977 Nov; 40(5):2136-51. PubMed ID: 72596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
    Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
    Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
    Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
    Jacobsen GK
    Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
    Alm P; Hultberg B; Olsson AM
    Scand J Urol Nephrol; 1984; 18(4):283-8. PubMed ID: 6209794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
    Morinaga S; Ojima M; Sasano N
    Cancer; 1983 Oct; 52(7):1281-9. PubMed ID: 6192898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferritin - another tumor marker for testicular malignancies.
    Engelmann U; Büber V; Riedmiller H; Jacobi GH
    Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Germ cell testicular tumors. Three therapeutic periods].
    Fargeot P
    Bull Cancer; 1990; 77(4):331-9. PubMed ID: 1693863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.